$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
恩杂鲁胺用药注意事项
2025-10-19 11:44:20
Check Details
英国阿斯利康的比卡鲁胺价格及规格
2025-10-19 11:44:20
Check Details
阿斯利康比卡鲁胺适应症
2025-10-19 11:44:20
Check Details
阿斯利康比卡鲁胺多少钱?
2025-10-19 11:44:20
Check Details
阿斯利康比卡鲁胺是医保药吗?
2025-10-19 11:44:20
Check Details
阿斯利康比卡鲁胺怎么购买?
2025-10-19 11:44:20
Check Details
阿斯利康比卡鲁胺效果怎么样?
2025-10-19 11:44:20
Check Details
阿斯利康比卡鲁胺多少钱一盒?
2025-10-19 11:44:20
Check Details
新一代AR抑制剂在非转移性去势抵抗性前列腺癌中仍发挥作用
2025-10-19 11:44:20
Check Details
泽珂用一个月要多少钱?
2025-10-19 11:44:20
Check Details
泽珂哪里有卖?
2025-10-19 11:44:20
Check Details
泽珂治疗效果怎么样?
2025-10-19 11:44:20
Check Details
1
2
...
1509
1510
1511
1512
1513
1514
1515
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Accelerates Approval of Zongertinib: Precision Medicine Advancement for HER2-Mutated NSCLC
2
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
3
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
4
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
5
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
6
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
7
Adagrasib Medication Management Guide for Special Populations
8
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
9
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
10
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
11
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
12
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers